While the share of ESI enrollees with a GLP-1 drug claim has been increasing, still only a relatively modest number of people have a claim Since 2012, the share of non-elderly adults with ESI that have a GLP-1 drug claim has grown more than eightfold (717.7% increase)
If your HRT provider does not prescribe GLP-1 medications, or vice versa, ensure that both providers communicate
Neuropsychopharmacol 40 , 19691978 (2015)
These include: Our goal is to redefine personalized healthcare, moving beyond one-time transactions to continuous care, said Beck
What the FDA prescribing information says The FDA-approved label for semaglutide injection (Ozempic) states: "Semaglutide causes a delay in gastric emptying, and thereby has the potential to impact the absorption of concomitantly administered oral medications." [3] The Wegovy label repeats this language verbatim, and the tirzepatide (Mounjaro) label carries an equivalent warning [4]
Why did my patient receive less than the prescribed amount of their medication